6843-49-8,MFCD00005265
Catalog No.:AA006JRG

6843-49-8 | 5-Methyl-5-phenylimidazolidine-2,4-dione

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$21.00   $15.00
- +
5g
98%
in stock  
$34.00   $24.00
- +
25g
98%
in stock  
$169.00   $118.00
- +
100g
98%
in stock  
$471.00   $330.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA006JRG
Chemical Name:
5-Methyl-5-phenylimidazolidine-2,4-dione
CAS Number:
6843-49-8
Molecular Formula:
C10H10N2O2
Molecular Weight:
190.1986
MDL Number:
MFCD00005265
SMILES:
O=C1NC(=O)NC1(C)c1ccccc1
NSC Number:
14839
Properties
Properties
 
Form:
Solid  
MP:
195-197°C  
Storage:
Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
271  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1  

Downstream Synthesis Route

[1]GreenChemistry,2017,vol.19,p.418-424

[2]Patent:US2561284,1947,

[3]JournalofOrganicChemistry,1957,vol.22,p.799,801

[4]Patent:WO2007/58601,2007,A1.Locationinpatent:Page/Pagecolumn75

[5]OrganicLetters,2015,vol.17,p.3838-3841

[1]Patent:US5270317,1993,A

CASUnavailable 
  506-87-6    98-86-2    6843-49-8 

[1]Monteiro,JuliaL.;Pieber,Bartholomäus;Corrêa,ArleneG.;Kappe,C.Oliver[Synlett,2016,vol.27,#1,p.83-87]

[2]Safari,Javad;Javadian,Leila[ComptesRendusChimie,2013,vol.16,#12,p.1165-1171]

[3]Safari,Javad;Gandomi-Ravandi,Soheila;Javadian,Leila[SyntheticCommunications,2013,vol.43,#23,p.3115-3120]

[4]Hussain,Abid;Kashif,MuhammadKalim;Naseer,MuhammadMoazzam;Rana,UsmanA.;Hameed,Shahid[ResearchonChemicalIntermediates,2015,vol.41,#10,p.7313-7326]

[5]Locationinpatent:experimentalpartTrisovic,Nemanja;Valentic,Natasa;Erovic,Marko;Dakovic-Sekulic,Tatjana;Uscumlic,Gordana;Juranic,Ivan[MonatsheftefurChemie,2011,vol.142,#12,p.1227-1234]

[6]Locationinpatent:experimentalpartCzopek,Anna;Byrtus,Hanna;Kołaczkowski,Marcin;Pawłowski,Maciej;Dybała,Małgorzata;Nowak,Gabriel;Tatarczyńska,Ewa;Wesołowska,Anna;Chojnacka-Wójcik,Ewa[EuropeanJournalofMedicinalChemistry,2010,vol.45,#4,p.1295-1303]

[7]Hmuda,SleemF.;Banjac,NebojsaR.;Trisovic,NemanjaP.;Bozic,BojanD.;Valentic,NatasaV.;Uscumlic,GordanaS.[JournaloftheSerbianChemicalSociety,2013,vol.78,#5,p.627-637]

[8]Kucwaj-Brysz,Katarzyna;Kurczab,Rafał;Jastrzębska-Więsek,Magdalena;Żesławska,Ewa;Satała,Grzegorz;Nitek,Wojciech;Partyka,Anna;Siwek,Agata;Jankowska,Agnieszka;Wesołowska,Anna;Kieć-Kononowicz,Katarzyna;Handzlik,Jadwiga[EuropeanJournalofMedicinalChemistry,2018,vol.147,p.102-114]

[9]Trisovic,Nemanja;Rogan,Jelena;Poleti,Dejan;Uscumlic,Gordana;Timic,Tamara;Divljakovic,Jovana;Savic,MiroslavM.[MonatsheftefurChemie,2012,vol.143,#10,p.1451-1457,7]

15008-33-0    6843-49-8   
5-(4-methyl-2,5-dioxo-4-phenylimidazolidin-1-yl)-N,N,N-trimethylpentan-1-aminiumbromide 

[1]Synlett,2016,vol.27,p.83-87

[1]CurrentPatentAssignee:ABBVIEINC-WO2016/44777,2016,A1Locationinpatent:Page/Pagecolumn56;57

[2]Kurczab,Rafal;Ali,Wesam;Łazewska,Dorota;Kotánska,Magdalena;Jastrzebska-Wiesek,Magdalena;Satała,Grzegorz;Wiecek,Małgorzata;Lubelska,Annamaria;Latacz,Gniewomir;Partyka,Anna;Starek,Małgorzata;Dabrowska,Monika;Wesołowska,Anna;Jacob,Claus;Kiéc-Kononowicz,Katarzyna;Handzlik,Jadwiga[Molecules,2018,vol.23,#10]

[3]Czopek,Anna;Kubacka,Monika;Bucki,Adam;Siwek,Agata;Filipek,Barbara;Pawłowski,Maciej;Kołaczkowski,Marcin[PharmacologicalReports,2021,vol.73,#5,p.1361-1372]

[4]Hassanin,MoamenA.;Mustafa,Muhamad;Abourehab,MohammedA.S.;Hassan,HebaA.;Aly,OmarM.;Beshr,EmanA.M.[Pharmaceuticals,2022,vol.15,#7]

Literature

Title: Solvent effects on the structure-property relationship of anticonvulsant hydantoin derivatives: A solvatochromic analysis.

Journal: Chemistry Central journal 20110101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Synthesis, physicochemical investigation and cytotoxic activity of new Pt(II) complexes with hydantoin ligands.

Journal: European journal of medicinal chemistry 20030601

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:6843-49-8 Molecular Formula|6843-49-8 MDL|6843-49-8 SMILES|6843-49-8 5-Methyl-5-phenylimidazolidine-2,4-dione
Catalog No.: AA006JRG
6843-49-8,MFCD00005265
6843-49-8 | 5-Methyl-5-phenylimidazolidine-2,4-dione
Pack Size: 1g
Purity: 98%
in stock
$21.00 $15.00
Pack Size: 5g
Purity: 98%
in stock
$34.00 $24.00
Pack Size: 25g
Purity: 98%
in stock
$169.00 $118.00
Pack Size: 100g
Purity: 98%
in stock
$471.00 $330.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA006JRG
Chemical Name: 5-Methyl-5-phenylimidazolidine-2,4-dione
CAS Number: 6843-49-8
Molecular Formula: C10H10N2O2
Molecular Weight: 190.1986
MDL Number: MFCD00005265
SMILES: O=C1NC(=O)NC1(C)c1ccccc1
NSC Number: 14839
Properties
Form: Solid  
MP: 195-197°C  
Storage: Inert atmosphere;2-8℃;  
Complexity: 271  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 14  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 1  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1  
Downstream Synthesis Route
6843-49-8    565-07-1 

[1]GreenChemistry,2017,vol.19,p.418-424

[2]Patent:US2561284,1947,

[3]JournalofOrganicChemistry,1957,vol.22,p.799,801

[4]Patent:WO2007/58601,2007,A1.Locationinpatent:Page/Pagecolumn75

[5]OrganicLetters,2015,vol.17,p.3838-3841

1066-33-7    98-86-2    6843-49-8 

[1]Patent:US5270317,1993,A

CASUnavailable 
  506-87-6    98-86-2    6843-49-8 

[1]Monteiro,JuliaL.;Pieber,Bartholomäus;Corrêa,ArleneG.;Kappe,C.Oliver[Synlett,2016,vol.27,#1,p.83-87]

[2]Safari,Javad;Javadian,Leila[ComptesRendusChimie,2013,vol.16,#12,p.1165-1171]

[3]Safari,Javad;Gandomi-Ravandi,Soheila;Javadian,Leila[SyntheticCommunications,2013,vol.43,#23,p.3115-3120]

[4]Hussain,Abid;Kashif,MuhammadKalim;Naseer,MuhammadMoazzam;Rana,UsmanA.;Hameed,Shahid[ResearchonChemicalIntermediates,2015,vol.41,#10,p.7313-7326]

[5]Locationinpatent:experimentalpartTrisovic,Nemanja;Valentic,Natasa;Erovic,Marko;Dakovic-Sekulic,Tatjana;Uscumlic,Gordana;Juranic,Ivan[MonatsheftefurChemie,2011,vol.142,#12,p.1227-1234]

[6]Locationinpatent:experimentalpartCzopek,Anna;Byrtus,Hanna;Kołaczkowski,Marcin;Pawłowski,Maciej;Dybała,Małgorzata;Nowak,Gabriel;Tatarczyńska,Ewa;Wesołowska,Anna;Chojnacka-Wójcik,Ewa[EuropeanJournalofMedicinalChemistry,2010,vol.45,#4,p.1295-1303]

[7]Hmuda,SleemF.;Banjac,NebojsaR.;Trisovic,NemanjaP.;Bozic,BojanD.;Valentic,NatasaV.;Uscumlic,GordanaS.[JournaloftheSerbianChemicalSociety,2013,vol.78,#5,p.627-637]

[8]Kucwaj-Brysz,Katarzyna;Kurczab,Rafał;Jastrzębska-Więsek,Magdalena;Żesławska,Ewa;Satała,Grzegorz;Nitek,Wojciech;Partyka,Anna;Siwek,Agata;Jankowska,Agnieszka;Wesołowska,Anna;Kieć-Kononowicz,Katarzyna;Handzlik,Jadwiga[EuropeanJournalofMedicinalChemistry,2018,vol.147,p.102-114]

[9]Trisovic,Nemanja;Rogan,Jelena;Poleti,Dejan;Uscumlic,Gordana;Timic,Tamara;Divljakovic,Jovana;Savic,MiroslavM.[MonatsheftefurChemie,2012,vol.143,#10,p.1451-1457,7]

15008-33-0    6843-49-8   
5-(4-methyl-2,5-dioxo-4-phenylimidazolidin-1-yl)-N,N,N-trimethylpentan-1-aminiumbromide 

[1]Synlett,2016,vol.27,p.83-87

506-87-6    98-86-2    6843-49-8 

[1]CurrentPatentAssignee:ABBVIEINC-WO2016/44777,2016,A1Locationinpatent:Page/Pagecolumn56;57

[2]Kurczab,Rafal;Ali,Wesam;Łazewska,Dorota;Kotánska,Magdalena;Jastrzebska-Wiesek,Magdalena;Satała,Grzegorz;Wiecek,Małgorzata;Lubelska,Annamaria;Latacz,Gniewomir;Partyka,Anna;Starek,Małgorzata;Dabrowska,Monika;Wesołowska,Anna;Jacob,Claus;Kiéc-Kononowicz,Katarzyna;Handzlik,Jadwiga[Molecules,2018,vol.23,#10]

[3]Czopek,Anna;Kubacka,Monika;Bucki,Adam;Siwek,Agata;Filipek,Barbara;Pawłowski,Maciej;Kołaczkowski,Marcin[PharmacologicalReports,2021,vol.73,#5,p.1361-1372]

[4]Hassanin,MoamenA.;Mustafa,Muhamad;Abourehab,MohammedA.S.;Hassan,HebaA.;Aly,OmarM.;Beshr,EmanA.M.[Pharmaceuticals,2022,vol.15,#7]

Literature fold

Title: Solvent effects on the structure-property relationship of anticonvulsant hydantoin derivatives: A solvatochromic analysis.

Journal: Chemistry Central journal20110101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Synthesis, physicochemical investigation and cytotoxic activity of new Pt(II) complexes with hydantoin ligands.

Journal: European journal of medicinal chemistry20030601

Building Blocks More >
919016-97-0
919016-97-0
[3-(2-Methoxyethoxy)phenyl]methanamine
AA006LFL | MFCD08690185
65864-60-0
65864-60-0
2,3,4,6-Tetra-O-acetyl-b-D-mannopyranosyl azide
AA006N04 | MFCD08703928
99556-74-8
99556-74-8
3-Methoxy-4-(2-(pyrrolidin-1-yl)ethoxy)benzaldehyde oxalate
AA006NK2 | MFCD05987481
94205-62-6
94205-62-6
2-(4-Amino-phenyl)-quinoline-4-carboxylic acid
AA006OJ6 | MFCD00178260
655247-45-3
655247-45-3
Ethyl 3-chloro-pyrazine-2-carboxylate
AA006PE9 | MFCD07371661
90417-29-1
90417-29-1
6-Amino-1h-indole-3-carboxylic acid
AA006QHX | MFCD13178386
64644-36-6
64644-36-6
1-[4-(3-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-2-hydroxypropoxy)phenyl]propan-1-one hydrochloride(1:1)
AA006RLP | MFCD00167989
915923-36-3
915923-36-3
3-(3,4-Dimethylphenoxy)-N-methylpropan-1-amine
AA006SVZ | MFCD08691950
98139-15-2
98139-15-2
4-Aminopyridine-2-carbonitrile
AA006TFZ | MFCD07374351
51690-67-6
51690-67-6
Benzenamine, 4-(4-ethoxyphenoxy)-
AA006U2M | MFCD07284192
Submit
© 2017 AA BLOCKS, INC. All rights reserved.